Shopping Cart
- Remove All
Your shopping cart is currently empty
Fontolizumab (HuZAF) is a humanised IgG1 monoclonal anti-IFN-gamma (IFN-γ) antibody with good tolerability and low immunogenicity. It is administered intravenously in clinical settings and can be used for the study of Crohn's disease.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $332 | In Stock | |
| 5 mg | $996 | In Stock | |
| 10 mg | $1,570 | In Stock |
| Description | Fontolizumab (HuZAF) is a humanised IgG1 monoclonal anti-IFN-gamma (IFN-γ) antibody with good tolerability and low immunogenicity. It is administered intravenously in clinical settings and can be used for the study of Crohn's disease. |
| Synonyms | HuZAF, Anti-Human IFNG Recombinant Antibody |
| Molecular Weight | 150 (kDa) |
| Cas No. | 326859-36-3 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.